Figure 1.
Immune cell types correlating with recurrence. The percentage of leukocyte RNA contributed by various immune cell types as estimated from tumor transcriptome data using CIBERSORT. Ratio of imputed percentages for Treg to rest of CD4+ T cells and lymphocytes to non-lymphocytic leukocytes was further used to confirm the differences in Treg and lymphocytes noted between recurrent and non-recurrent lung adenocarcinoma. Significant differences are denoted as *p < 0.05, **p < 0.01, ***p < 0.001 and ****p < 0.0001.